Roche acquires Irish inflammasome company Inflazome for €380m
Roche acquisition of Inflazome : Swiss drug giant Roche has acquired Irish biotech company Inflazome, a developer of inflammasome inhibitors, for an upfront payment of €380 million. The Irish pharma company will also stand to get additional contingent payments, which will be based on the meeting of certain predetermined milestones. Inflazome was a portfolio company […]